Join
Live feed
·
INSIDERFilingvia Quantisnow
AbCellera Biologics Inc. logo

Director Hayden Michael R bought $570,442 worth of shares (53,613 units at $10.64) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ABCL· AbCellera Biologics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABCL (AbCellera Biologics Inc.) and more on Quantisnow.